Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 3/20 | 0.72 |
| ▸ | DRD4 | P21917 | 2/20 | 0.68 |
| ▸ | MCHR1 | Q99705 | 15/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4246591 | 0.92 | MCHR1 (0.66) | CCR3DRD4MCHR1 | |
| SCHEMBL4240454 | 0.92 | CCR3 (0.59) | CCR3DRD4MCHR1 | |
| SCHEMBL4238071 | 0.92 | CCR3 (0.59) | CCR3DRD4MCHR1 | |
| SCHEMBL4236492 | 0.91 | DRD4 (0.71) | DRD4MCHR1 | |
| SCHEMBL4246600 | 0.91 | MCHR1 (0.72) | CCR3DRD4MCHR1 | |
| SCHEMBL3145442 | 0.90 | MCHR1 (0.80) | CCR3DRD4MCHR1 | |
| Hydrochloric Acid SCHEMBL3149079 | 0.89 | MCHR1 (0.78) | CCR3DRD4MCHR1 | |
| Bromide SCHEMBL3136407 | 0.89 | MCHR1 (0.78) | CCR3DRD4MCHR1 | |
| SCHEMBL4236450 | 0.87 | MCHR1 (0.56) | CCR3DRD4MCHR1 | |
| SCHEMBL4238501 | 0.86 | MCHR1 (0.56) | CCR3DRD4MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081825-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-2098509-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | Taisho Pharmaceutical Co. Ltd. (JP) | 2009-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081825-A1 | 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE | MCHR1, MCHR2, MC5R | CCR3 4143/4885DRD4 130/4885MCHR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.